Methodologies Adopted in Drug Repurposing
- 29 August 2024
- book chapter
- Published by Springer Nature
- p. 13-27
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant Plasmodium falciparumMedicinal Research Reviews, 2019
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)European Journal of Immunology, 2019
- Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning StudyPharmaceutical Research, 2015
- DrugNet: Network-based drug–disease prioritization by integrating heterogeneous dataArtificial Intelligence in Medicine, 2015
- Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's DiseaseNeurotherapeutics, 2015
- Cheminformatics at the interface of medicinal chemistry and proteomicsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2014
- The Collaborative Drug Discovery (CDD) Database2013
- In silico repositioning of approved drugs for rare and neglected diseasesDrug Discovery Today, 2011
- Walking the Interactome for Prioritization of Candidate Disease GenesThe American Journal of Human Genetics, 2008